| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Nucleotide-binding oligomerization domain-containing protein 2 |
|---|
| Ligand | BDBM54367 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | uHTS luminescence assay for the identification of compounds that inhibit NOD2 in MDP treated cells |
|---|
| IC50 | 103±n/a nM |
|---|
| Citation |  PubChem, PC uHTS luminescence assay for the identification of compounds that inhibit NOD2 in MDP treated cells PubChem Bioassay(2010)[AID] |
|---|
| More Info.: | Get all data from this article, Solution Info, Assay Method |
|---|
| |
| Nucleotide-binding oligomerization domain-containing protein 2 |
|---|
| Name: | Nucleotide-binding oligomerization domain-containing protein 2 |
|---|
| Synonyms: | CARD15 | Caspase recruitment domain-containing protein 15 | IBD1 | Inflammatory bowel disease protein 1 | NOD2 | NOD2_HUMAN | Nucleotide-binding oligomerization domain-containing protein 2 | nucleotide-binding oligomerization domain containing 2 |
|---|
| Type: | PROTEIN |
|---|
| Mol. Mass.: | 115287.18 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | ChEMBL_1454053 |
|---|
| Residue: | 1040 |
|---|
| Sequence: | MGEEGGSASHDEEERASVLLGHSPGCEMCSQEAFQAQRSQLVELLVSGSLEGFESVLDWL
LSWEVLSWEDYEGFHLLGQPLSHLARRLLDTVWNKGTWACQKLIAAAQEAQADSQSPKLH
GCWDPHSLHPARDLQSHRPAIVRRLHSHVENMLDLAWERGFVSQYECDEIRLPIFTPSQR
ARRLLDLATVKANGLAAFLLQHVQELPVPLALPLEAATCKKYMAKLRTTVSAQSRFLSTY
DGAETLCLEDIYTENVLEVWADVGMAGPPQKSPATLGLEELFSTPGHLNDDADTVLVVGE
AGSGKSTLLQRLHLLWAAGQDFQEFLFVFPFSCRQLQCMAKPLSVRTLLFEHCCWPDVGQ
EDIFQLLLDHPDRVLLTFDGFDEFKFRFTDRERHCSPTDPTSVQTLLFNLLQGNLLKNAR
KVVTSRPAAVSAFLRKYIRTEFNLKGFSEQGIELYLRKRHHEPGVADRLIRLLQETSALH
GLCHLPVFSWMVSKCHQELLLQEGGSPKTTTDMYLLILQHFLLHATPPDSASQGLGPSLL
RGRLPTLLHLGRLALWGLGMCCYVFSAQQLQAAQVSPDDISLGFLVRAKGVVPGSTAPLE
FLHITFQCFFAAFYLALSADVPPALLRHLFNCGRPGNSPMARLLPTMCIQASEGKDSSVA
ALLQKAEPHNLQITAAFLAGLLSREHWGLLAECQTSEKALLRRQACARWCLARSLRKHFH
SIPPAAPGEAKSVHAMPGFIWLIRSLYEMQEERLARKAARGLNVGHLKLTFCSVGPTECA
ALAFVLQHLRRPVALQLDYNSVGDIGVEQLLPCLGVCKALYLRDNNISDRGICKLIECAL
HCEQLQKLALFNNKLTDGCAHSMAKLLACRQNFLALRLGNNYITAAGAQVLAEGLRGNTS
LQFLGFWGNRVGDEGAQALAEALGDHQSLRWLSLVGNNIGSVGAQALALMLAKNVMLEEL
CLEENHLQDEGVCSLAEGLKKNSSLKILKLSNNCITYLGAEALLQALERNDTILEVWLRG
NTFSLEEVDKLGCRDTRLLL
|
|
|
|---|
| BDBM54367 |
|---|
| n/a |
|---|
| Name | BDBM54367 |
|---|
| Synonyms: | 2-[(4E)-1-(1,3-benzothiazol-2-yl)-4-[1-(4-methoxyanilino)ethylidene]-5-oxo-3-pyrazolyl]acetic acid methyl ester | 2-[(4E)-1-(1,3-benzothiazol-2-yl)-5-keto-4-[1-(p-anisidino)ethylidene]-2-pyrazolin-3-yl]acetic acid methyl ester | MLS000778899 | SMR000415593 | cid_16460826 | methyl 2-[(4E)-1-(1,3-benzothiazol-2-yl)-4-[1-(4-methoxyanilino)ethylidene]-5-oxopyrazol-3-yl]acetate | methyl 2-[(4E)-1-(1,3-benzothiazol-2-yl)-4-[1-[(4-methoxyphenyl)amino]ethylidene]-5-oxidanylidene-pyrazol-3-yl]ethanoate | {1-Benzothiazol-2-yl-4-[1-(4-methoxy-phenylamino)-eth-(E)-ylidene]-5-oxo-4,5-dihydro-1H-pyrazol-3-yl}- acetic acid methyl ester |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C22H20N4O4S |
|---|
| Mol. Mass. | 436.484 |
|---|
| SMILES | COC(=O)Cc1[nH]n(-c2nc3ccccc3s2)c(=O)c1C(C)=Nc1ccc(OC)cc1 |w:22.25| |
|---|
| Structure | 
|
|---|
Search and Browse
